Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice

Journal of Autoimmunity

Volumn 32, Issue 2, 2009, Pages 85-93

  Xiao, Xiaoyan ^a,b   Ma, Bin ^a,c   Dong, Baojun ^a   Zhao, Peng ^d   Tai, Ningwen ^a   Chen, Li ^b   Susan Wong, F ^e   Wen, Li ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHANDONG UNIVERSITY   (China)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d SHANDONG UNIVERSITY   (China)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Diabetic nephropathy; Immune response; Kidney; Non obese diabetic mice

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3; GLYCOPROTEIN P 15095; GRANZYME B; INSULIN ANTIBODY; PERFORIN;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPLEMENT DEPOSITION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; DIABETIC NEUROPATHY; ELECTRON MICROSCOPY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN DEPOSITION; IMMUNOPATHOLOGY; KIDNEY HYPERTROPHY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ALBUMINURIA; ANIMALS; ANTIBODY FORMATION; AUTOANTIBODIES; CD8-POSITIVE T-LYMPHOCYTES; DIABETIC NEPHROPATHIES; FEMALE; GENE EXPRESSION REGULATION; GRANZYMES; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; MICE; MICE, INBRED NOD; MICROSCOPY, ELECTRON, TRANSMISSION; PERFORIN; RNA, MESSENGER;

EID: 62149114830     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.12.003     Document Type: Article

References (29)

1. Gross J.L., de Azevedo M.J., Silveiro S.P., Canani L.H., Caramori M.L., and Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28 (2005) 164-176
2. Perkins B.A., Ficociello L.H., Silva K.H., Finkelstein D.M., Warram J.H., and Krolewski A.S. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348 (2003) 2285-2293
3. Marshall S.M. Recent advances in diabetic nephropathy. Postgrad Med J 80 (2004) 624-633
4. Osterby R., Parving H.H., Hommel E., Jorgensen H.E., and Lokkegaard H. Glomerular structure and function in diabetic nephropathy. Early to advanced stages. Diabetes 39 (1990) 1057-1063
5. Schrijvers B.F., De Vriese A.S., and Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 25 (2004) 971-1010
6. Cooper M.E. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 44 (2001) 1957-1972
7. Paulsen E.P., Burke B.A., Vernier R.L., Mallare M.J., Innes Jr. D.J., and Sturgill B.C. Juxtaglomerular body abnormalities in youth-onset diabetic subjects. Kidney Int 45 (1994) 1132-1139
8. Moriya R., Manivel J.C., and Mauer M. Juxtaglomerular apparatus T-cell infiltration affects glomerular structure in type 1 diabetic patients. Diabetologia 47 (2004) 82-88
9. Lewis A., Steadman R., Manley P., Craig K., de la Motte C., Hascall V., et al. Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis. Histol Histopathol 23 (2008) 731-739
10. Giarratana N., Penna G., and Adorini L. Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse. Methods Mol Biol 380 (2007) 285-311
11. Breyer M.D., Bottinger E., Brosius III F.C., Coffman T.M., Harris R.C., Heilig C.W., et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol 16 (2005) 27-45
12. Maeda M., Yabuki A., Suzuki S., Matsumoto M., Taniguchi K., and Nishinakagawa H. Renal lesions in spontaneous insulin-dependent diabetes mellitus in the nonobese diabetic mouse: acute phase of diabetes. Vet Pathol 40 (2003) 187-195
13. Jeansson M., Granqvist A.B., Nystrom J.S., and Haraldsson B. Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice. Diabetologia 49 (2006) 2200-2209
14. Hu C.Y., Rodriguez-Pinto D., Du W., Ahuja A., Henegariu O., Wong F.S., et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 117 (2007) 3857-3867
15. Baxter A.G., and Cooke A. Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice. Diabetes 42 (1993) 1574-1578
16. Ichinose K., Kawasaki E., and Eguchi K. Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy. Am J Nephrol 27 (2007) 554-564
17. Bending J.J., Lobo-Yeo A., Vergani D., and Viberti G.C. Proteinuria and activated T-lymphocytes in diabetic nephropathy. Diabetes 37 (1988) 507-511
18. Saraheimo M., Teppo A.M., Forsblom C., Fagerudd J., and Groop P.H. Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients. Diabetologia 46 (2003) 1402-1407
19. Hovind P., Hansen T.K., Tarnow L., Thiel S., Steffensen R., Flyvbjerg A., et al. Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study. Diabetes 54 (2005) 1523-1527
20. Saraheimo M., Forsblom C., Hansen T.K., Teppo A.M., Fagerudd J., Pettersson-Fernholm K., et al. Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia 48 (2005) 198-202
21. Imani F., Horii Y., Suthanthiran M., Skolnik E.Y., Makita Z., Sharma V., et al. Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling. J Exp Med 178 (1993) 2165-2172
22. Silveira P.A., and Baxter A.G. The NOD mouse as a model of SLE. Autoimmunity 34 (2001) 53-64
23. Baxter A.G., Horsfall A.C., Healey D., Ozegbe P., Day S., Williams D.G., et al. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 83 (1994) 227-231
24. Nicoloff G., Blazhev A., Petrova C., and Christova P. Circulating immune complexes among diabetic children. Clin Dev Immunol 11 (2004) 61-66
25. Atchley D.H., Lopes-Virella M.F., Zheng D., Kenny D., and Virella G. Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy. Diabetologia 45 (2002) 1562-1571
26. Virella G., Carter R.E., Saad A., Crosswell E.G., Game B.A., and Lopes-Virella M.F. Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy. Clin Immunol 127 (2008) 394-400
27. Fineberg S.E., Kawabata T.T., Finco-Kent D., Fountaine R.J., Finch G.L., and Krasner A.S. Immunological responses to exogenous insulin. Endocr Rev 28 (2007) 625-652
28. Ostergaard J., Hansen T.K., Thiel S., and Flyvbjerg A. Complement activation and diabetic vascular complications. Clin Chim Acta 361 (2005) 10-19
29. Nguyen C.Q., Kim H., Cornelius J.G., and Peck A.B. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6. NOD-Aec1Aec2 mice is dependent on complement component-3. J Immunol 179 (2007) 2318-2329